Literature DB >> 25108887

Prostate cancer screening comes of age.

Ian M Thompson1, Catherine M Tangen2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25108887     DOI： 10.1016/S0140-6736(14)61008-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Prostate-specific antigen testing: good or bad?

Authors:  Peter C Albertsen
Journal:  Oncologist       Date:  2015-02-11

2.  MicroRNA-143 acts as a tumor suppressor by targeting hexokinase 2 in human prostate cancer.

Authors:  Peng Zhou; Wei-Guo Chen; Xiao-Wei Li
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

3.  Polypeptide-Based Molecular Platform and Its Docetaxel/Sulfo-Cy5-Containing Conjugate for Targeted Delivery to Prostate Specific Membrane Antigen.

Authors:  Stanislav A Petrov; Aleksei E Machulkin; Anastasia A Uspenskaya; Nikolay Y Zyk; Ekaterina A Nimenko; Anastasia S Garanina; Rostislav A Petrov; Vladimir I Polshakov; Yuri K Grishin; Vitaly A Roznyatovsky; Nikolay V Zyk; Alexander G Majouga; Elena K Beloglazkina
Journal:  Molecules       Date:  2020-12-08       Impact factor: 4.411

Review 4.  Cancer prevention as part of precision medicine: 'plenty to be done'.

Authors:  Bernard W Stewart; Freddie Bray; David Forman; Hiroko Ohgaki; Kurt Straif; Andreas Ullrich; Christopher P Wild
Journal:  Carcinogenesis       Date:  2015-11-20       Impact factor: 4.944

5.  LINC00689 promotes prostate cancer progression via regulating miR-496/CTNNB1 to activate Wnt pathway.

Authors:  Liwei Meng; Zhonghai Li; Ye Chen; Deqian Liu; Zhaoxu Liu
Journal:  Cancer Cell Int       Date:  2020-06-05       Impact factor: 5.722
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.